Ticker LaunchIPO · AMYT
Amryt Pharma plc
Formerly Amryt Pharma Holdings Ltd
Amryt Pharma plc (AMYT) priced its initial public offering on Jul 8, 2020, and listed on Nasdaq Global Select.
Amryt Pharma plc is a commercial-stage biopharmaceutical company focused on rare diseases. It sells lomitapide for homozygous familial hypercholesterolemia and metreleptin for lipodystrophy, and its lead candidate, AP101, is in a pivotal Phase 3 trial for epidermolysis bullosa.
- Status
- IPO
- Ticker
- AMYT
- Exchange
- Nasdaq Global Select
- Priced
- Jul 8, 2020
- First filed
- Jun 23, 2020
- Sector
- Biotech & pharma
- Country / state
- United Kingdom
More on this listing for subscribers
- Lock-up period and expiry date
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed Jun 23, 2020
- Latest amendment Jul 7, 2020
- Final prospectus (424B4) Jul 8, 2020
- All filings on EDGAR CIK 1783010
Other Biotech & pharma IPOs in 2020
- ALX Oncology Holdings IncALXO · Jul 17, 2020 · $161.5M
- Relay Therapeutics, Inc.RLAY · Jul 16, 2020 · $400M
- Inventiva S.A.IVA · Jul 13, 2020 · $107.7M
- Nkarta, Inc.NKTX · Jul 13, 2020 · $252M
- Poseida Therapeutics, Inc.PSTX · Jul 10, 2020 · $224M
- Aditxt, Inc.ADTX · Jul 1, 2020 · $11M